Literature DB >> 33932502

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).

S Bellone1, D M Roque2, E R Siegel3, N Buza1, P Hui1, E Bonazzoli1, A Guglielmi1, L Zammataro1, N Nagarkatti1, S Zaidi4, J Lee5, D-A Silasi6, G S Huang1, V Andikyan1, S Damast1, M Clark1, M Azodi1, P E Schwartz1, J Tymon-Rosario1, J Harold1, D Mauricio1, B Zeybek1, G Menderes1, G Altwerger1, E Ratner1, L B Alexandrov7, A Iwasaki1, Y Kong1, E Song1, W Dong8, J Elvin9, J Choi5, A D Santin10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33932502      PMCID： PMC9465821          DOI： 10.1016/j.annonc.2021.04.013

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   51.769


× No keyword cloud information.
  3 in total

1.  Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.

Authors:  Janelle B Pakish; Qian Zhang; Zhongyuan Chen; Han Liang; Gary B Chisholm; Ying Yuan; Samuel C Mok; Russell R Broaddus; Karen H Lu; Melinda S Yates
Journal:  Clin Cancer Res       Date:  2017-03-06       Impact factor: 12.531

2.  Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.

Authors:  Siming Zhao; Stefania Bellone; Salvatore Lopez; Durga Thakral; Carlton Schwab; Diana P English; Jonathan Black; Emiliano Cocco; Jungmin Choi; Luca Zammataro; Federica Predolini; Elena Bonazzoli; Mark Bi; Natalia Buza; Pei Hui; Serena Wong; Maysa Abu-Khalaf; Antonella Ravaggi; Eliana Bignotti; Elisabetta Bandiera; Chiara Romani; Paola Todeschini; Renata Tassi; Laura Zanotti; Franco Odicino; Sergio Pecorelli; Carla Donzelli; Laura Ardighieri; Fabio Facchetti; Marcella Falchetti; Dan-Arin Silasi; Elena Ratner; Masoud Azodi; Peter E Schwartz; Shrikant Mane; Roberto Angioli; Corrado Terranova; Charles Matthew Quick; Babak Edraki; Kaya Bilgüvar; Moses Lee; Murim Choi; Amy L Stiegler; Titus J Boggon; Joseph Schlessinger; Richard P Lifton; Alessandro D Santin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

3.  Classification and characterization of microsatellite instability across 18 cancer types.

Authors:  Ronald J Hause; Colin C Pritchard; Jay Shendure; Stephen J Salipante
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440
  3 in total
  3 in total

1.  How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review.

Authors:  Brigida Anna Maiorano; Mauro Francesco Pio Maiorano; Gennaro Cormio; Annamaria Maglione; Domenica Lorusso; Evaristo Maiello
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

2.  A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.

Authors:  Stefania Bellone; Dana M Roque; Eric R Siegel; Natalia Buza; Pei Hui; Elena Bonazzoli; Adele Guglielmi; Luca Zammataro; Nupur Nagarkatti; Samir Zaidi; Jungsoo Lee; Dan-Arin Silasi; Gloria S Huang; Vaagn Andikyan; Shari Damast; Mitchell Clark; Masoud Azodi; Peter E Schwartz; Joan R Tymon-Rosario; Justin A Harold; Dennis Mauricio; Burak Zeybek; Gulden Menderes; Gary Altwerger; Elena Ratner; Ludmil B Alexandrov; Akiko Iwasaki; Yong Kong; Eric Song; Weilai Dong; Julia A Elvin; Jungmin Choi; Alessandro D Santin
Journal:  Cancer       Date:  2021-12-07       Impact factor: 6.921

3.  Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.

Authors:  Yoland Antill; Daniel D Buchanan; Clare L Scott
Journal:  Cancer       Date:  2021-12-07       Impact factor: 6.921
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.